Used as an intermediate in the synthesis of pharmaceuticals, particularly in the production of fluoro-substituted drugs that exhibit enhanced metabolic stability and bioavailability. Commonly employed in the development of non-steroidal anti-inflammatory drugs (NSAIDs) and other biologically active compounds where fluorine substitution improves target binding and pharmacokinetic properties. Also utilized in the preparation of liquid crystals for display technologies due to its ability to influence mesomorphic behavior when incorporated into molecular structures. Its difluoro substitution pattern provides electronic and steric characteristics favorable for fine-tuning material and drug candidate performance.